TABLE 4.
Crude* | Model 1† | Model 2† | Model 3† | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
B | β | P | BF | B | β | P | BF | B | β | P | BF | B | β | P | BF | |
Diagnosis (ref: healthy) | ||||||||||||||||
Schizophrenia | −0.76 | −0.51 | <0.000 | >1000 | −0.51 | −0.34 | 0.000 | >1000 | −0.51 | −0.34 | 0.000 | >1000 | −0.24 | −0.16 | 0.085 | 3.0 |
Depression | −0.30 | −0.29 | 0.002 | 15.0 | −0.31 | −0.22 | 0.004 | 63.7 | −0.31 | −0.22 | 0.006 | 33.1 | −0.19 | −0.13 | 0.089 | 2.4 |
Age | −0.03 | −0.47 | <0.000 | >1000 | −0.02 | −0.33 | 0.000 | >1000 | −0.02 | −0.33 | 0.000 | >1000 | −0.02 | −0.30 | <0.000 | >1000 |
Women (ref: men) | 0.27 | 0.21 | 0.013 | 3.1 | 0.10 | 0.07 | 0.316 | 1.9 | 0.09 | 0.07 | 0.348 | 1.1 | 0.10 | 0.08 | 0.277 | 1.1 |
Ongoing physical activity | <0.00 | −0.24 | 0.005 | 5.9 | <0.00 | −0.22 | 0.002 | 76.6 | <0.00 | −0.22 | 0.002 | 43.1 | <0.00 | −0.20 | 0.004 | 16.8 |
Nicotine use (ref: no use) | −0.21 | −0.15 | 0.082 | 0.7 | −0.02 | −0.01 | 0.888 | 0.7 | −0.02 | −0.01 | 0.871 | 0.6 | ||||
BMI | −0.03 | −0.29 | <0.000 | 64.9 | <0.00 | −0.01 | 0.895 | 0.8 | <0.00 | <0.00 | 0.992 | 0.7 | ||||
Anticholinergic burden | −0.16 | −0.49 | <0.000 | >1000 | −0.10 | −0.31 | <0.000 | 114.3 |
*All analyses are bivariate.
†Multivariate analysis of all variables below and n = 136 in all analyses including ongoing physical activity due to 8 participants without acceleration data (see “Ongoing physical activity during HRV recording” section).
BF indicates Bayes factor; logHF, logarithmic high frequency.